US Patent Issued to NantCell on Jan. 20 for "HLA clusters, global frequencies, and binding across SARS-CoV-2 variation" (California Inventor)

ALEXANDRIA, Va., Jan. 20 -- United States Patent no. 12,531,134, issued on Jan. 20, was assigned to NantCell Inc. (Culver City, Calif.).

"HLA clusters, global frequencies, and binding across SARS-CoV-2 variation" was invented by Kamil Wnuk (Playa del Rey, Calif.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Techniques are provided for determining pan-HLA binding of viral proteins. A trained classifier model is operable to determine, independently per HLA, at least one of (a) an average binding prediction of overlapping peptides at each position of a viral protein, (b) a maximum value of a binding prediction of overlapping peptides at each position of the viral protein, (c) standard deviation of a binding pr...